Strides Pharma Science Ltd Quarterly Results
Q1 FY26-27 Results Summary
Revenue
The revenue stands at ₹1,265.41 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 4.39 per cent from ₹1,323.47 crore. This corresponds to a year-on-year *(YoY) growth of 13.01 per cent.
Operating Profit
Operating Profit stands at ₹228.49 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 2.06 per cent from ₹233.30 crore. This corresponds to a year-on-year *(YoY) growth of 8.96 per cent.
PBDT
PBDT stands at ₹256.02 crore, reflecting a quarter-on-quarter *(QoQ) increase of 27.18 per cent from ₹201.30 crore. This corresponds to a year-on-year *(YoY) growth of 49.77 per cent.
Profit Before Tax
Profit Before Tax stands at ₹199.62 crore, reflecting a quarter-on-quarter *(QoQ) increase of 34.83 per cent from ₹148.05 crore. This corresponds to a year-on-year *(YoY) growth of 63.56 per cent.
Net Profit
Net Profit stands at ₹165.49 crore, reflecting a quarter-on-quarter *(QoQ) increase of 28.01 per cent from ₹129.28 crore. This represents a 56.71 per cent year-on-year *(YoY) growth for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Strides Pharma Science Ltd News
Strides Pharma Science Ltd Earnings
- YOY
- QOQ
Strides Pharma Science Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Strides Pharma Science Ltd Research Reports
| Action | Target Price (₹) | Broker | Date | Reports |
|---|---|---|---|---|
| Data Not Found | ||||
Strides Pharma Science Ltd Financial Reports
Strides Pharma Science Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Strides Pharma | -0.05% | 0.89% | -6.55% | -12.37% | 17.16% | 15.39% |
| Sanofi Consumer | 0.98% | -0.18% | -0.42% | -1.10% | 5.82% | -10.69% |
| Orchid Pharma | -0.15% | 7.64% | 6.71% | 54.64% | 61.78% | 40.03% |
| P & G Health Ltd | 1.39% | -0.70% | -11.94% | 15.76% | 21.49% | -2.20% |
| Aarti Pharma | 7.32% | 27.84% | 22.91% | 24.83% | 24.52% | 11.61% |
| Sanofi India | -0.79% | -1.53% | -1.28% | 1.62% | -18.38% | -34.82% |
| Supriya Lifesci. | -7.96% | -4.21% | 0.86% | 25.04% | 25.21% | 30.23% |
Company Info
Company Information
Chairman & Non Executive Dir. : Arun Kumar
Group CEO & Executive Director : Badree Komandur
Executive Director & COO : VENKATA SEETHARAMA RAJU PAKALAPATI
Independent Non Exe. Director : Kausalya Santhanam
Independent Non Exe. Director : Mukta Malik Arora
Independent Non Exe. Director : Subir Chakraborty
Independent Non Exe. Director : Homi R Khusrokhan
Independent Non Exe. Director : Ameet Hariani
Company Sec. & Compli. Officer : Manjula Ramamurthy